4.6 Article

MHC Class I and TCR Avidity Control the CD8 T Cell Response to IL-15/IL-15Rα Complex

Journal

JOURNAL OF IMMUNOLOGY
Volume 185, Issue 11, Pages 6857-6865

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1001601

Keywords

-

Categories

Funding

  1. NIAID NIH HHS [R01 AI051583-08, R01 AI051583, R01 AI051583-09, R01 AI051583-07] Funding Source: Medline

Ask authors/readers for more resources

IL-15 operates via a unique mechanism termed transpresentation. In this system, IL-15 produced by one cell type is bound to IL-15R alpha expressed by the same cell and is presented to apposing cells expressing the IL-15R beta/gamma C complex. We have shown that administering soluble IL-15R alpha complexed with IL-15 can greatly enhance IL-15 activity. We now show that the naive CD8 T cell response to exogenous IL-15/IL-15R alpha complex is MHC class I dependent. In the absence of beta 2 microglobulin, naive CD8 T cells scarcely proliferated in response to IL-15/IL-15R alpha complex, whereas memory cells proliferated, although to a lesser extent, compared with levels in control mice. The loss of beta 2m or FcRn slightly reduced the extended half-life of IL-15/IL-15R alpha complex, whereas FcRn deficiency only partially reduced the naive CD8 T cell proliferative response to IL-15/IL-15R alpha complex. In addition, we demonstrated a link between TCR avidity and the ability of a T cell to respond to IL-15/IL-15R alpha complex. Thus, T cells expressing low-avidity TCR responded poorly to IL-15/IL-15R alpha complex, which correlated with a poor homeostatic proliferative response to lymphopenia. The inclusion of cognate peptide along with complex resulted in enhanced proliferation, even when TCR avidity was low. IL-15/IL-15R alpha complex treatment, along with peptide immunization, also enhanced activation and the migratory ability of responding T cells. These data suggest that IL-15/IL-15R alpha complex has selective effects on Ag-activated CD8 T cells. Our findings have important implications for directing IL-15/IL-15R alpha complex-based therapy to specific Ag targets and illustrate the possible adjuvant uses of IL-15/IL-15R alpha complex. The Journal of Immunology, 2010, 185: 6857-6865.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available